Zydus Lifesciences Limited (Zydus), in partnership with MSN Laboratories Private Limited (MSN), today announced the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg, in the United ...

Wells Fargo upgraded Sweetgreen and raised its price target, citing easing Cyclospora concerns and improving traffic. ・HSBC upgraded Target, while KeyBanc raised Airbnb on durable growth and hotel ...

A new commentary argues that spirometry alone cannot detect the silent gas exchange and pulmonary vascular abnormalities affecting survivors of extreme preterm birth, calling for comprehensive ...

Isometric exercise training -- such as squats and plank exercises -- was best done three times a week for short-term blood pressure (BP)-lowering benefits, a randomized study foun ...

New Delhi, Oct 5 (PTI): Zydus Lifesciences Limited, in a partnership with MSN Laboratories Private Limited, has launched the ...

Zydus Lifesciences and MSN Laboratories launch the first generic Riociguat tablets in the US across five strengths after ...

IntroductionCurrent Status and Challenges of TAVI for Aortic StenosisLast time, I wrote about the progress of TAVI from 2018 ...

"Lately, my ring is hard to take off," "My fingers turn white or purple when it's cold," "The skin on my hands feels ...

YUTREPIA’s adoption is translating into profits and cash, giving Liquidia an operating foundation for further growth. Click ...

Zydus Lifesciences (Zydus), in partnership with MSN Laboratories (MSN), has announced the launch of Riociguat Tablets, 0.5 mg ...

Zydus Lifesciences Limited (Zydus), in partnership with MSN Laboratories Private Limited (MSN), announced the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg, in the United States.

A new review maps how skin signs of six systemic autoimmune rheumatic diseases can flag hidden interstitial lung disease ...